APPLICATION
ANDA207294
TYPE
ANDA
ORIGINAL APPROVAL
2024-11-21
LATEST ACTION
2024-11-21
ROUTE
ORAL
DOSAGE FORM
POWDER
MARKETING STATUS
Prescription
Products
CHOLESTYRAMINEPrescription
CHOLESTYRAMINE EQ 4GM RESIN/SCOOPFUL · POWDER · ORAL
CHOLESTYRAMINEPrescription
CHOLESTYRAMINE EQ 4GM RESIN/PACKET · POWDER · ORAL
Approval history
2024-11-21UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.